Stay on Top of Inpatient Treatment Options for COVID-19

June 2020

You’ll continue to see updates on COVID-19 treatments.

Anecdotal and observational data are making headlines...often without peer review. But these results don’t paint the whole picture...and often downplay risks. Plus no treatment is FDA-approved.

Save the chart, COVID-19 and Pharmacotherapy, as a “Favorite” on our website...to get periodic updates on efficacy, side effects, etc.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber Insights: APRN includes:

Cutting-edge advice about new medications and how they fit into practice
Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get a quote

Practice Help Patients and Staff Understand Test Results
Dermatology Manage Skin Irritation Due to Handwashing
Anticoagulants Be Prepared to Treat and Prevent VTE Due to Cancer
Infectious Diseases Put Treatments for COVID-19 in Perspective
Immunizations Keep Immunizations on Track During COVID-19
Poison Prevention Provide Strategies to Prevent Poisonings
Infectious Diseases Settle Debate About Vancomycin or Fidaxomicin for C. diff
Allergic Reactions Address Barriers to Getting Epinephrine for Anaphylaxis
Practice Weigh the Situation When Patients Ask About Expiration Dates
Infectious Diseases Stay on Top of Inpatient Treatment Options for COVID-19
New Drugs Explain Why IV Cetirizine Shouldn’t Be on Formulary

Stay on Top of Inpatient Treatment Options for COVID-19

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Table of Contents